Human papillomavirus and cervical cancer
KS Okunade - Journal of Obstetrics and Gynaecology, 2020 - Taylor & Francis
Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical
cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) …
cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) …
Portfolio theory: as I still see it
HM Markowitz - Annu. Rev. Financ. Econ., 2010 - annualreviews.org
This essay summarizes my views on (a) the foundations of portfolio theory and its
applications to current issues, such as the choice of criteria for practical risk-return analysis …
applications to current issues, such as the choice of criteria for practical risk-return analysis …
Human papillomavirus and cervical cancer
EM Burd - Clinical microbiology reviews, 2003 - Am Soc Microbiol
Of the many types of human papillomavirus (HPV), more than 30 infect the genital tract. The
association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well …
association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well …
Natural history of cervicovaginal papillomavirus infection in young women
GYF Ho, R Bierman, L Beardsley… - New England Journal …, 1998 - Mass Medical Soc
Background Genital human papillomavirus (HPV) infection is highly prevalent in sexually
active young women. However, precise risk factors for HPV infection and its incidence and …
active young women. However, precise risk factors for HPV infection and its incidence and …
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia
M Schiffman, SK Kjaer - JNCi monographs, 2003 - academic.oup.com
This chapter suggests promising areas of future epidemiologic research on human
papillomavirus (HPV) and anogenital cancer, organized around our understanding of …
papillomavirus (HPV) and anogenital cancer, organized around our understanding of …
Age-specific prevalence of infection with human papillomavirus in females: a global review
JS Smith, A Melendy, RK Rana, JM Pimenta - Journal of Adolescent Health, 2008 - Elsevier
PURPOSE: Global data on age-specific prevalence of human papillomavirus (HPV) infection
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica
R Herrero, A Hildesheim, C Bratti… - Journal of the …, 2000 - academic.oup.com
BACKGROUND: Human papillomavirus (HPV) is the main cause of cervical neoplasia.
Because few population-based studies have investigated the prevalence of type-specific …
Because few population-based studies have investigated the prevalence of type-specific …
Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide
S Franceschi, R Herrero, GM Clifford… - … journal of cancer, 2006 - Wiley Online Library
An inverse relationship between age and human papillomavirus (HPV) prevalence has
been reported in many developed countries, but information on this relationship is scarce in …
been reported in many developed countries, but information on this relationship is scarce in …
Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
JM Palefsky, H Minkoff, LA Kalish… - Journal of the …, 1999 - academic.oup.com
BACKGROUND: Human papillomavirus (HPV) infection is associated with precancerous
cervical squamous intraepithelial lesions commonly seen among women infected with …
cervical squamous intraepithelial lesions commonly seen among women infected with …
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
Background: Human papillomavirus (HPV) vaccine may be commercially available in a few
years. We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 …
years. We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 …